Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.31 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11856272 | 1.00 | TDP1 (0.35) | TDP1KMT2ARAB9ASMN1; SMN2CYP2C9 | |
| SCHEMBL11856278 | 1.00 | TDP1 (0.35) | TDP1KMT2ARAB9ASMN1; SMN2CYP2C9 | |
| SCHEMBL22991020 | 0.80 | MCL1 (0.32) | MCL1 | |
| SCHEMBL19019704 | 0.80 | TDP1 (0.30) | TDP1 | |
| SCHEMBL13821259 | 0.80 | CYP2C9 (0.31) | TDP1CYP2C9KDM4E | |
| SCHEMBL11809406 | 0.79 | — | — | |
| SCHEMBL26755 | 0.79 | — | — | |
| SCHEMBL13891834 | 0.79 | — | — | |
| SCHEMBL1959929 | 0.79 | — | — | |
| SCHEMBL11809392 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795357-B2 | Poly(etherimide-phthalonitrile) adhesives and related methods | THE BOEING COMPANY (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230063744-A1 | Polymerizable Compositions Including a Phthalonitrile Resin and a Polyoxometalate, Articles, and Methods | 3M INNOVATIVE PROPERTIES COMPANY | 2023-03-02 | — | — | US | disclosed |
| US-20200299506-A1 | BISPHENOL M DIPHTHALONITRILE ETHER RESIN BLENDS INCLUDING A FILLER, AND ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY | 2020-09-24 | — | — | US | disclosed |
| US-10640598-B2 | Resin blends of resorcinol diphthalonitrile ether with bisphenol M diphthalonitrile ether and/or bisphenol T diphthalonitrile ether | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-05-05 | — | — | US | disclosed |
| US-10556991-B2 | Benzoxazine and phthalonitrile resin blends | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-02-11 | — | — | US | disclosed |
| US-20190055338-A1 | RESIN BLENDS OF RESORCINOL DIPHTHALONITRILE ETHER WITH BISPHENOL M DIPHTHALONITRILE ETHER AND/OR BISPHENOL T DIPHTHALONITRILE ETHER | 3M INNOVATIVE PROPERTIES COMPANY | 2019-02-21 | — | — | US | disclosed |
| US-20190047946-A1 | BISPHENOL M DIPHTHALONITRILE ETHER RESIN, BISPHENOL P DIPHTHALONITRILE ETHER RESIN, METHODS OF MAKING SAME, RESIN BLENDS, AND TWO COMPONENT SYSTEMS | 3M INNOVATIVE PROPERTIES COMPANY | 2019-02-14 | — | — | US | disclosed |
| WO-2017105890-A1 | BENZOXAZINE AND PHTHALONITRILE RESIN BLENDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10640598-B2 | Resin blends of resorcinol diphthalonitrile ether with bisphenol M diphthalonitrile ether and/or bisphenol T diphthalonitrile ether | WDR48, CUL4A, FHIT | TDP1 3131/4885KMT2A 1368/4885RAB9A 2419/4885 |
| US-20190055338-A1 | RESIN BLENDS OF RESORCINOL DIPHTHALONITRILE ETHER WITH BISPHENOL M DIPHTHALONITRILE ETHER AND/OR BISPHENOL T DIPHTHALONITRILE ETHER | WDR48, CUL4A, FHIT | TDP1 3131/4885KMT2A 1368/4885RAB9A 2419/4885 |
| US-20190047946-A1 | BISPHENOL M DIPHTHALONITRILE ETHER RESIN, BISPHENOL P DIPHTHALONITRILE ETHER RESIN, METHODS OF MAKING SAME, RESIN BLENDS, AND TWO COMPONENT SYSTEMS | PNN, POLN, RBBP4 | TDP1 1791/4885KMT2A 1321/4885RAB9A 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.